Oxiracetam

Oxiracetam
Product Description

Psychostimulant


From our Korean Partner Sam Oh Pharm.Co., Ltd

Read more Show less

Miat SpA

  • IT
  • 2018
    On CPHI since
View company profile

Miat SpA

  • IT
  • 2018
    On CPHI since
View company profile

More Products from Miat SpA (45)

  • Monodose DPI's (Dry Powder Inhalers) and monodose nasal Insufflators

    Product Monodose DPI's (Dry Powder Inhalers) and monodose nasal Insufflators

    Monodose DPI's and monodose nasal insufflators
  • DPI's and pMDI's Specialities

    Product DPI's and pMDI's Specialities

    Dry Powder Inhalers and pressurized Metered-Dose Inhalers monodose and multidose presentations
  • Mequitazine

    Product Mequitazine

    Histamine H1 antagonist (antihistamine).
  • NP container

    Product NP container

    Ophthalmic multi-dose container preservative free
  • Levodropropizine

    Product Levodropropizine

    Antitussive


    From our Korean Partner Sam Oh Pharm.Co., Ltd
  • Methylprednisolone Aceponate

    Product Methylprednisolone Aceponate



    Corticosteroids
    From our Korean Partner Sam Oh Pharm.Co., Ltd
  • Pioglitazone HCl

    Product Pioglitazone HCl

    Antidiabetic


    From our Korean Partner Sam Oh Pharm.Co., Ltd

  • Teriflunomide

    Product Teriflunomide

    Multiple Sclerosis

    From our Korean Partner Sam Oh Pharm.Co., Ltd

  • Tiropramide HCl

    Product Tiropramide HCl

    Gastrointestinal disorder

    From our Korean Partner Sam Oh Pharm.Co., Ltd

  • Trientine HCl

    Product Trientine HCl

    Wilson's disease

    From our Korean Partner Sam Oh Pharm.Co., Ltd

  • Diclofenac Epolamine Medicated Plaster

    Product Diclofenac Epolamine Medicated Plaster

    MIAT has developed and registered (Hybrid legal basis) in some European countries a medicated plaster based on Diclofenc Epolamine for the symptomatic local treatment of pain and inflammation of rheumatic or traumatic nature of joints, muscles, tendons and ligaments. The product is available only through i...
  • Sodium Hyaluronate (HA)

    Product Sodium Hyaluronate (HA)

    Miat offers Sodium Hyaluronate (i.e. HA) obtained by fermentation from Streptococcus equi subsp. Zooepidemicus, intended for Pharmaceutical  (available IV range 0.6-3.6 m3/kg) and Medical Device use (available IV range 0.1-3.6 m3/kg). The offered HA is supported by European documentation i.e. the ...
show all 45 other products